No. | Description | Set size | Enrichment score | p value adjusted |
---|---|---|---|---|
1 | Graft-versus-host disease | 35 | 0.82 | 0.01 |
2 | Intestinal immune network for IgA production | 43 | 0.80 | 0.01 |
3 | Rheumatoid arthritis | 84 | 0.77 | 0.01 |
4 | Malaria | 46 | 0.77 | 0.01 |
5 | Systemic lupus erythematosus | 46 | 0.77 | 0.01 |
6 | Asthma | 26 | 0.76 | 0.01 |
7 | Autoimmune thyroid disease | 46 | 0.75 | 0.01 |
8 | Type I diabetes mellitus | 39 | 0.74 | 0.01 |
9 | Leishmaniasis | 71 | 0.73 | 0.01 |
10 | Inflammatory bowel disease | 61 | 0.70 | 0.01 |
11 | Legionellosis | 53 | 0.68 | 0.01 |
12 | Pertussis | 69 | 0.68 | 0.01 |
13 | African trypanosomiasis | 34 | 0.65 | 0.01 |
14 | Tuberculosis | 169 | 0.61 | 0.01 |
15 | Viral myocarditis | 54 | 0.61 | 0.01 |
16 | Staphylococcus aureus infection | 75 | 0.60 | 0.01 |
17 | Measles | 130 | 0.59 | 0.01 |
18 | Epstein-Barr virus infection | 191 | 0.59 | 0.01 |
19 | Kaposi sarcoma-associated herpesvirus infection | 183 | 0.58 | 0.01 |
20 | Prion diseases | 34 | 0.58 | 0.04 |
21 | Toxoplasmosis | 104 | 0.58 | 0.01 |
22 | Influenza A | 157 | 0.56 | 0.01 |
23 | Human T-cell leukemia virus 1 infection | 213 | 0.56 | 0.01 |
24 | Hepatitis B | 158 | 0.54 | 0.01 |
25 | Human cytomegalovirus infection | 214 | 0.51 | 0.01 |
26 | Acute myeloid leukemia | 66 | 0.50 | 0.02 |
27 | Yersinia infection | 117 | 0.46 | 0.01 |
28 | Viral carcinogenesis | 162 | 0.45 | 0.01 |
29 | Human immunodeficiency virus 1 infection | 196 | 0.44 | 0.01 |
30 | Hepatitis C | 149 | 0.39 | 0.05 |
31 | Shigellosis | 207 | 0.37 | 0.03 |
32 | Salmonella infection | 211 | 0.37 | 0.03 |
33 | Human papillomavirus infection | 317 | 0.33 | 0.04 |